Advancing the development of tuberculosis therapy

@article{Zumla2012AdvancingTD,
  title={Advancing the development of tuberculosis therapy},
  author={Alimuddin Zumla and R. Hafner and C. Lienhardt and M. Hoelscher and A. Nunn},
  journal={Nature Reviews Drug Discovery},
  year={2012},
  volume={11},
  pages={171-172}
}
Although the development of novel drugs and combination regimens for tuberculosis has accelerated in recent years, the pipeline remains thin and major challenges remain to be addressed in efficiently evaluating newer drugs to improve treatment outcomes, shorten duration of therapy and tackle drug resistance. 

Topics from this paper

Using combination therapy to thwart drug resistance.
Is adjuvant therapy a potential road for fighting Mycobacterium tuberculosis resistance?
  • M. Martins
  • Medicine
  • Expert review of anti-infective therapy
  • 2012
Antimicrobial peptides as novel anti-tuberculosis therapeutics.
Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis
Addressing the Challenges of Tuberculosis: A Brief Historical Account
...
1
2
3
4
5
...

References

SHOWING 1-4 OF 4 REFERENCES
2011 update
  • WHO website [online], http://whqlibdoc.who.int/ publications/2011/9789241501583_eng.pdf
  • 2012
Global tuberculosis control 2010